Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Achaogen Inc (AKAO)

Achaogen Inc (AKAO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,027
  • Shares Outstanding, K 63,880
  • Annual Sales, $ 8,730 K
  • Annual Income, $ -186,510 K
  • 60-Month Beta 0.78
  • Price/Sales 0.79
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.74
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/03/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.47
  • Number of Estimates 2
  • High Estimate -0.33
  • Low Estimate -0.61
  • Prior Year -0.98
  • Growth Rate Est. (year over year) +52.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.10 +7.84%
on 04/25/19
0.60 -81.66%
on 04/04/19
-0.40 (-78.64%)
since 03/25/19
3-Month
0.10 +7.84%
on 04/25/19
1.88 -94.15%
on 01/29/19
-1.27 (-92.03%)
since 01/25/19
52-Week
0.10 +7.84%
on 04/25/19
15.00 -99.27%
on 05/01/18
-12.97 (-99.16%)
since 04/25/18

Most Recent Stories

More News
Achaogen, Inc. Announces Results of Auction for Substantially All Company Assets

Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced today it has reached...

AKAO : 0.11 (unch)
Achaogen (AKAO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Achaogen (AKAO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AKAO : 0.11 (unch)
Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65%

Achaogen (AKAO) files for bankruptcy in a district court. Shares slump 65% on the announcement.

ESALY : 55.1700 (+0.04%)
AKAO : 0.11 (unch)
ASRT : 3.00 (+2.39%)
BSTC : 60.87 (-0.21%)
Achaogen Plans for Near-Term Sale Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code

Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced today...

AKAO : 0.11 (unch)
New Research Coverage Highlights Hewlett Packard Enterprise, Sunstone Hotel Investors, NTN Buzztime, Seadrill Partners, Achaogen, and China Automotive -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Hewlett Packard Enterprise Company...

SDLP : 3.14 (-5.99%)
AKAO : 0.11 (unch)
NTN : 3.18 (-0.98%)
SHO : 13.15 (-0.68%)
HPE : 14.84 (+0.61%)
CAAS : 2.28 (+6.54%)
Achaogen (AKAO) Upgraded to Buy: Here's Why

Achaogen (AKAO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AKAO : 0.11 (unch)
Is the Options Market Predicting a Spike in Achaogen (AKAO) Stock?

Investors need to pay close attention to Achaogen (AKAO) stock based on the movements in the options market lately.

AKAO : 0.11 (unch)
Achaogen: 4Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Achaogen Inc. (AKAO) on Thursday reported a loss of $47.5 million in its fourth quarter.

AKAO : 0.11 (unch)
Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2018 Financial Results on March 28, 2019

Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today...

AKAO : 0.11 (unch)
Infection Control Seizes Headlines as Companies Look to Tackle Food-Borne Illnesses

The growing concern over infectious diseases developing in facilities, such as hospitals, has caused a demand for products to combat the spread. These diseases are caused by pathogenic microorganisms such...

AKAO : 0.11 (unch)
CAG : 28.90 (-0.72%)
FLO : 23.49 (-0.42%)
CRMD : 9.06 (+0.33%)
PCTL : 0.0092 (+206.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade AKAO with:

Business Summary

Achaogen, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant, or MDR, gram-negative infections. The Company is developing plazomicin, its lead product candidate, for the treatment...

See More

Key Turning Points

2nd Resistance Point 0.22
1st Resistance Point 0.17
Last Price 0.11
1st Support Level 0.08
2nd Support Level 0.05

See More

52-Week High 15.00
Fibonacci 61.8% 9.31
Fibonacci 50% 7.55
Fibonacci 38.2% 5.79
Last Price 0.11
52-Week Low 0.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar